March 27, 2017

ALEXANDRIA, Va., Toronto, Canada - The American Society of Clinical Oncology (ASCO) and Cancer Care Ontario today issued a joint clinical practice guideline update on brachytherapy (internal radiation) for patients with prostate cancer. The update provides evidence-based recommendations for different patient risk groups, and specifies the most effective forms of brachytherapy.

March 22, 2017

WASHINGTON – The U.S. cancer care delivery system is undergoing profound changes to better meet the needs of people with cancer, but persistent hurdles threaten to slow progress, according to the American Society of Clinical Oncology’s (ASCO) fourth annual State of Cancer Care in America report released today.

March 21, 2017

ALEXANDRIA, Va. -- QOPI Certification Program LLC (QCP), an affiliate of the American Society of Clinical Oncology, Inc. (ASCO) that runs the QOPI Certification Program™, and the Foundation for Excellence and Quality in Oncology (ECO), a nonprofit foundation in Spain, have launched an effort to expand the QOPI Certification Program to Spain. Through the collaboration between ECO and QCP, Spanish oncology practices will be able to apply for QOPI Certification.

March 17, 2017

ALEXANDRIA, Va. - The American Society of Clinical Oncology (ASCO) today issued a clinical practice guideline on human papillomavirus (HPV) vaccination for the prevention of cervical cancer. This is the first guideline on primary prevention of cervical cancer that is tailored to multiple regions of the world with different levels of socio-economic and structural resource settings, offering evidence-based guidance to health care providers worldwide. 

March 16, 2017

We soundly oppose President Trump’s budget outline, which would cut $6 billion from the National Institutes of Health (NIH). Reducing NIH’s funding by nearly 20 percent will devastate our nation’s already fragile federal research infrastructure and undercut a longstanding commitment to biomedical science that has fueled advances in cancer prevention, diagnosis, and treatment.

March 14, 2017

A new study demonstrates that the use of less radiation therapy (RT) for breast cancer patients who have undergone lumpectomy does not negatively impact patient outcomes, and could result in significant reductions in health care costs. These findings, which examine patient eligibility for evidence-based radiation therapies or no RT in the National Cancer Database (NCDB), were published online today in the Journal of Oncology Practice. People living with breast cancer often receive lumpectomy followed by RT instead of a full mastectomy because research has demonstrated that there is no difference in disease-specific or overall survival.

March 14, 2017

ALEXANDRIA, Va. -- On March 22, 2017, the American Society of Clinical Oncology (ASCO) will release The State of Cancer Care in America: 2017 report, which examines the current landscape of the cancer care delivery system in the United States, and outlines key opportunities and challenges facing cancer care providers and patients today.

March 13, 2017

“The American Society of Clinical Oncology (ASCO) congratulates Seema Verma for her confirmation as Administrator of the Centers for Medicare & Medicaid Services (CMS). Administrator Verma is now in a key position to lead the agency during the next phase of healthcare reform in the United States, and to help ensure that millions of Medicare and Medicaid beneficiaries with cancer have access to high-quality oncology care."

March 8, 2017

ALEXANDRIA, Va. --  CancerLinQ LLC, a wholly-owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO), and the Oncology Nursing Society (ONS) announced today the formation of the CancerLinQ® Ambassadors Program. This new collaboration is a national practice engagement initiative that will provide on-the-ground support and guidance to CancerLinQ® participating practices on a regional basis.

March 4, 2017

Alexandria, VA. – The Journal of Oncology Practice (JOP) today will publish three articles being presented in oral sessions at ASCO’s 2017 Quality Care Symposium (QCS) in Orlando, FL. In its aim to provide top resources on clinical and administrative management for the oncology field, JOP is extending its publishing territory to work with researchers and publish the latest findings in conjunction with meeting presentations.

March 3, 2017

ALEXANDRIA, Va. – Four studies exploring key issues in providing high-quality patient care will be presented at the 2017 Quality Care Symposium, taking place March 3–4, at Rosen Shingle Creek in Orlando, FL. These notable abstracts examine and implement various approaches to improving the quality of treatment and care for patients with cancer.

February 27, 2017

ALEXANDRIA, Va. – An influx of new oral cancer drugs provides patients with a more convenient and less invasive way to take medication, but such treatments are often associated with adherence challenges and medical errors. New research shows that the addition of an in-house specialty pharmacy at a cancer center in New Haven, Connecticut, improved overall quality of care for patients, reduced the amount of time it took patients to receive their medication, and prevented errors associated with filling, dispensing, and taking oral chemotherapy. Authors will present their findings at the American Society of Clinical Oncology’s (ASCO) upcoming Quality Care Symposium, taking place March 3-4, in Orlando, Florida.

February 27, 2017

ALEXANDRIA, Va. – As an increasing number of patients look to the internet for cancer information, researchers from the University of Alabama found that the websites of many National Cancer Institute (NCI)-designated cancer centers lack sufficient information to help patients with breast cancer understand all their treatment options and make well-informed decisions. It also found they are not fully accessible to Spanish-speaking patients and those using mobile devices. In contrast, websites of the NCI and the Susan G. Komen® had high-quality patient information. Researchers will present their findings at the American Society of Clinical Oncology’s (ASCO) upcoming Quality Care Symposium, taking place March 3-4, in Orlando, Florida.

February 27, 2017

ALEXANDRIA, Va. – A new analysis of data from the U.S. Military Health System finds that mood and adjustment disorders such as anxiety and depression were strong predictors of the annual number of outpatient visits, hospital admissions, and number of days in the hospital for patients with breast and prostate cancer. The study also found that between 2007 and 2014, mood and adjustment disorders increased 7% (21% to 28%) among breast cancer patients and 4% (9% to 13%) among prostate cancer patients. However, during this period the rate at which depression increased was identical for both groups. Authors will present their findings at the American Society of Clinical Oncology’s (ASCO) upcoming Quality Care Symposium, taking place March 3-4, in Orlando, Florida.

February 27, 2017

ALEXANDRIA, Va. – The embargo has lifted on all abstracts from the 2017 Quality Care Symposium. Journalists may now report on these abstracts, which are publicly available at abstracts.asco.org.

Pages